Analysts 15 incl. previous ratings
Rating Distribution 8 Buy · 7 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jun 12, 2026 Initiated B Bernstein
Mkt Perform $96 -1.5% Apr 21, 2026 Upgrade R Rothschild & Co Redburn
Neutral → Buy $100 +2.6% Mar 31, 2026 Downgrade T TD Cowen
Buy → Hold $85 -12.8% Mar 30, 2026 Upgrade D Deutsche Bank
Hold → Buy $98 +0.6% Jan 13, 2026 Upgrade W Wells Fargo
Underweight → Equal Weight $86 -11.7% Jan 07, 2026 Upgrade P Piper Sandler
Neutral → Overweight $88 -9.7% Dec 11, 2025 Downgrade A Argus
Buy → Hold Dec 09, 2025 Upgrade R RBC Capital Mkts
Sector Perform → Outperform $88 -9.7% Oct 03, 2025 Resumed P Piper Sandler
Neutral $84 -13.8% Oct 28, 2024 Downgrade S Stifel
Buy → Hold $105 → $101 +3.7% Sep 24, 2024 Initiated P Piper Sandler
Overweight $121 +24.2% Sep 16, 2024 Downgrade W Wells Fargo
Equal Weight → Underweight $100 +2.6% Sep 09, 2024 Downgrade D Deutsche Bank
Buy → Hold $107 → $109 +11.9% Jul 26, 2024 Downgrade H HSBC Securities
Buy → Hold Jul 24, 2024 Downgrade J Jefferies
Buy → Hold $103 → $95 -2.5% Jul 23, 2024 Initiated T TD Cowen
Buy $110 +12.9% Jun 24, 2024 Initiated E Exane BNP Paribas
Outperform $109 +11.9% Mar 01, 2024 Resumed G Goldman
Buy $93 -4.5% Jan 29, 2024 Upgrade R Raymond James
Mkt Perform → Outperform Dec 15, 2023 Upgrade B BofA Securities
Neutral → Buy $90 -7.6%
Show Previous Ratings
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin Aug 24 '26 Sale 92.05 10,000 920,477 64,901 Aug 26 04:47 PM Tsourapas Panagiotis Officer Aug 24 '26 Proposed Sale 92.05 10,000 920,477 Aug 24 04:49 PM CAHILL JOHN T Director Aug 06 '26 Option Exercise 71.56 4,170 298,405 32,543 Aug 07 05:23 PM CAHILL JOHN T Director Aug 06 '26 Sale 93.37 4,170 389,358 28,373 Aug 07 05:23 PM CAHILL JOHN T Director Aug 06 '26 Proposed Sale 93.37 4,170 389,358 Aug 06 04:55 PM Wallace Noel R. Chairman, President & CEO Aug 04 '26 Option Exercise 72.29 161,021 11,640,208 523,252 Aug 06 04:27 PM Wallace Noel R. Chairman, President & CEO Aug 05 '26 Option Exercise 72.29 161,021 11,640,208 523,252 Aug 06 04:27 PM Wallace Noel R. Chairman, President & CEO Aug 05 '26 Sale 92.52 161,021 14,897,904 362,231 Aug 06 04:27 PM Wallace Noel R. Chairman, President & CEO Aug 04 '26 Sale 91.92 161,021 14,800,712 362,231 Aug 06 04:27 PM Wallace Noel R. Officer Aug 05 '26 Proposed Sale 92.52 161,021 14,897,912 Aug 05 04:10 PM Wallace Noel R. Officer Aug 04 '26 Proposed Sale 91.92 161,021 14,800,720 Aug 04 04:39 PM CAHILLANE STEVEN A Officer Aug 04 '26 Proposed Sale 90.57 1,762 159,584 Aug 04 04:38 PM Malcolm Gregory EVP and Controller May 15 '26 Sale 88.44 2,300 203,412 13,598 May 18 04:06 PM Massey Sally Chief People Officer May 07 '26 Sale 87.41 8,599 751,633 13,785 May 11 04:05 PM Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin Feb 11 '26 Option Exercise 76.41 35,000 2,674,350 45,415 Feb 13 04:25 PM Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin Feb 12 '26 Option Exercise 76.41 15,000 1,146,150 25,415 Feb 13 04:25 PM Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin Feb 11 '26 Sale 94.61 35,000 3,311,326 10,415 Feb 13 04:25 PM Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin Feb 12 '26 Sale 97.81 15,000 1,467,111 10,415 Feb 13 04:25 PM Tsourapas Panagiotis Officer Feb 12 '26 Proposed Sale 97.81 15,000 1,467,111 Feb 12 04:30 PM Hazlin John Chief Growth Officer Feb 10 '26 Option Exercise 76.41 20,989 1,603,769 38,634 Feb 12 04:08 PM Hazlin John Chief Growth Officer Feb 10 '26 Sale 94.25 20,989 1,978,211 17,645 Feb 12 04:08 PM Tsourapas Panagiotis Officer Feb 11 '26 Proposed Sale 94.61 35,000 3,311,325 Feb 11 04:05 PM Malcolm Gregory EVP and Controller Feb 06 '26 Option Exercise 76.41 12,747 973,998 24,626 Feb 10 04:21 PM Malcolm Gregory EVP and Controller Feb 06 '26 Sale 94.91 12,747 1,209,822 11,879 Feb 10 04:21 PM Hazlin John Officer Feb 10 '26 Proposed Sale 94.25 20,989 1,978,211 Feb 10 04:17 PM Massey Sally Chief Human Resources Officer Feb 05 '26 Option Exercise 76.41 15,851 1,211,175 29,602 Feb 09 04:16 PM Massey Sally Chief Human Resources Officer Feb 05 '26 Sale 95.03 15,851 1,506,287 13,751 Feb 09 04:16 PM SUTULA STANLEY J III Chief Financial Officer Feb 04 '26 Option Exercise 81.78 97,843 8,001,601 153,153 Feb 06 04:06 PM SUTULA STANLEY J III Chief Financial Officer Feb 04 '26 Sale 94.27 97,843 9,223,288 55,310 Feb 06 04:06 PM Daniels Jennifer CLO and Secretary Feb 04 '26 Option Exercise 72.29 22,000 1,590,380 98,406 Feb 06 04:05 PM Daniels Jennifer CLO and Secretary Feb 04 '26 Sale 94.34 22,000 2,075,399 76,406 Feb 06 04:05 PM Wallace Noel R. Chairman, President & CEO Feb 04 '26 Sale 93.91 45,568 4,279,496 293,188 Feb 06 04:04 PM Daniels Jennifer Officer Feb 04 '26 Proposed Sale 94.34 22,000 2,075,398 Feb 04 04:23 PM Wallace Noel R. Officer Feb 04 '26 Proposed Sale 93.91 45,568 4,279,497 Feb 04 04:22 PM SUTULA STANLEY J III Officer Feb 04 '26 Proposed Sale 94.27 97,843 9,223,284 Feb 04 04:20 PM Massey Sally Chief Human Resources Officer Nov 21 '25 Sale 80.89 1,237 100,061 13,751 Nov 24 04:04 PM
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Chairman Mr. Noel R. Wallace
Chief Financial Officer Mr. Stanley J. Sutula III
COO of Global Customer Dev. Mr. Panagiotis Tsourapas
Chief Operating Officer of Americas Mr. Shane Grant
Chief Technology Officer Mr. Stephan Habif